A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.
ASIC targets AMP execs in fees for no service probe, court told
Acciona mulls settlement with NSW Government in light rail dispute
AMP contractor pleads guilty to stealing customer data
Wyeth defends validity of patents in trial over best-selling Prevnar 13 vaccine
Pharmaceutical giant Wyeth has shot down arguments by rival Merck Sharp & Dohme that its Prevnar 13 vaccine lacked inventiveness, saying during the closing submissions of a high-stakes patent trial that up until it developed the top-selling shot scientists thought there was a “ceiling” of 11 types of pneumococcal bacteria that could be included in a single vaccine.